☆ 4.6 Article

Change of the Neutrophil-to-Lymphocyte Ratio during Treatment: A Potential Prognostic Biomarker in Metastatic Prostate Cancer Treated with Radium-223 Dichloride

CANCERS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Radiology, Nuclear Medicine & Medical Imaging

The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)

Matteo Bauckneht et al.

Summary: This study developed a prognostic score, the BIO-Ra score, to predict the survival of mCRPC patients treated with [Ra-223] RaCl2. By analyzing various peripheral blood indices and clinical factors, three prognostic groups were identified, effectively predicting the median survival of patients.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

添加到收藏夹

Article Oncology

Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study

Matteo Bauckneht et al.

Summary: This study found that the BIO-Ra score, based on inflammatory indices and clinical factors, can still predict the prognosis and treatment completion rate of patients with metastatic castration-resistant prostate cancer receiving Radium-223 treatment, even in the context of restricted use.

CANCERS (2022)

添加到收藏夹

Review Cell Biology

The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules

Yona Keisari et al.

Summary: Radiation therapy can destroy tumors and activate anti-tumor immune responses, but often cannot induce effective immune response alone. Immunotherapy can complement radiation therapy to enhance anti-tumor immunity and better eradicate cancer cells.

CELLS (2021)

添加到收藏夹

Review Oncology

Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses

Georges Mjaess et al.

Summary: The NLR is a significant prognostic marker for urological tumors, predicting survival outcomes in various types of cancer and should be integrated into prognostic tools for these cancers.

ACTA ONCOLOGICA (2021)

添加到收藏夹

Article Oncology

Prostate Cancer, Version 1.2021 Featured Updates to the NCCN Guidelines

Edward Schaeffer et al.

Summary: The NCCN Guidelines for Prostate Cancer provide recommendations for staging and risk assessment post-diagnosis, with management options for localized, regional, and metastatic disease. The guidelines also cover disease monitoring and treatment of recurrent disease. The NCCN Prostate Cancer Panel meets annually to update recommendations based on new clinical data, aiming to provide the most effective care for patients.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

添加到收藏夹

Article Oncology

Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study

R. de Wit et al.

Summary: The study showed that high baseline neutrophil-to-lymphocyte ratio (NLR) predicts poor outcomes with androgen-receptor-targeted agents (ARTA) in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel and alternative ARTA, while the activity of cabazitaxel remains consistent regardless of NLR.

ESMO OPEN (2021)

添加到收藏夹

Article Oncology

Toxicity and Efficacy of Concurrent Androgen Deprivation Therapy, Pelvic Radiotherapy, and Radium-223 in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer

Philip G. Turner et al.

Summary: This study investigated the safety and efficacy of combination therapy with radium-223 and pelvic EBRT for de novo bone metastatic mHSPC patients, showing a safe treatment option with promising efficacy signals, a high overall tumor response or stability rate among patients.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Oncology

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

Laura Mezquita et al.

Summary: In patients with aNSCLC receiving ICI treatment, high dNLR at baseline (B) correlated with worse PFS/OS, while high dNLR at cycle 2 (C2) was associated with even poorer outcomes. Persistently high dNLR (B+C2) was linked to early ICI failure, suggesting immature neutrophils may play a key role in ICI resistance.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Review Oncology

Prostate Cancer Immunotherapy-Finally in From the Cold?

Karie D. Runcie et al.

Summary: Despite challenges posed by low tumor mutational burden and limited immunogenicity, recent research in deciphering immune resistance mechanisms in the prostate tumor microenvironment has led to the discovery of new treatment targets. These discoveries are currently being translated into innovative immunotherapy clinical trials for patients with prostate cancer, showing early evidence of activity and potential predictive biomarkers of response.

CURRENT ONCOLOGY REPORTS (2021)

添加到收藏夹

Article Oncology

Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors

Lihong Peng et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

添加到收藏夹

Meeting Abstract Oncology

The prognostic value of the baseline neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving radium-223 (Ra-223): A post-hoc analysis of the ALSYMPCA phase-III trial

A. Meisel et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Review Medicine, General & Internal

Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies

Meghan A. Cupp et al.

BMC MEDICINE (2020)

添加到收藏夹

Article Oncology

The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors

Luke R. G. Pike et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

添加到收藏夹

Review Oncology

Epidemiology of Prostate Cancer

Prashanth Rawla

WORLD JOURNAL OF ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma

Aly-Khan A. Lalani et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

添加到收藏夹

Article Oncology

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Mariaelena Capone et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

添加到收藏夹

Review Surgery

Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis

Jinan Guo et al.

INTERNATIONAL JOURNAL OF SURGERY (2018)

添加到收藏夹

Article Oncology

Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel

Consuelo Buttigliero et al.

ACTA ONCOLOGICA (2017)

添加到收藏夹

Article Oncology

Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use

D. Lorente et al.

ANNALS OF ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials

R. J. van Soest et al.

ANNALS OF ONCOLOGY (2015)

添加到收藏夹

Article Urology & Nephrology

Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel

Ahmet Taner Sumbul et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)

添加到收藏夹

Review Oncology

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

Arnoud J. Templeton et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

添加到收藏夹

Article Oncology

Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy

Anthony Linton et al.

CLINICAL GENITOURINARY CANCER (2013)

添加到收藏夹

Article Medicine, General & Internal

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

C. Parker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Review Oncology

Role of T lymphocytes in tumor response to radiotherapy

Sandra Demaria et al.

FRONTIERS IN ONCOLOGY (2012)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

CELL (2011)

添加到收藏夹

Article Biology

Failla Memorial Lecture - A sense of danger from radiation

WH McBride et al.

RADIATION RESEARCH (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.